Asset Details
Do you wish to reserve the book?
Annexin-A1 Regulates MicroRNA-26b and MicroRNA-562 to Directly Target NF-kappaB and Angiogenesis in Breast Cancer Cells
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Annexin-A1 Regulates MicroRNA-26b and MicroRNA-562 to Directly Target NF-kappaB and Angiogenesis in Breast Cancer Cells
Do you wish to request the book?
Annexin-A1 Regulates MicroRNA-26b and MicroRNA-562 to Directly Target NF-kappaB and Angiogenesis in Breast Cancer Cells
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Annexin-A1 Regulates MicroRNA-26b and MicroRNA-562 to Directly Target NF-kappaB and Angiogenesis in Breast Cancer Cells
2014
Overview
Annexin 1 (ANXA1) is an endogenous anti-inflammatory protein implicated in cancer. ANXA1 was previously shown to be regulated by hsa-miR-196a. However, whether ANXA1 itself regulates microRNA (miR) expression is unknown. Therefore, we investigated the regulation of miR by ANXA1 in MCF7 breast cancer cells. MCF7-EV (Empty vector) and MCF7-V5 (ANXA1-V5 expressing cells) were subjected to a miR microarray. Microarray analysis revealed a number of miRNAs which were dysregulated in MCF7-V5 cells. 2 novel miRNAs (miR562 and miR26b*) were validated, cloned and functionally characterized. As ANXA1 constitutively activates NF-[kappa]B activity to modulate breast cancer metastasis, we found that miR26b* and miR562 directly targeted the canonical NF-[kappa]B pathway by targeting the 3' UTR and inhibiting expression of Rel A (p65) and NF-[kappa]B1 (p105) respectively. MiR562 inhibited wound healing, which was reversed when ANXA1 was overexpressed. Overexpression of either miR562 or miR26b* in MCF-7 cells enhanced endothelial tube formation when cocultured with human umbilical cord endothelial cells while conversely, treatment of MCF7 cells with either anti-miR562 or anti-miR26b* inhibited endothelial tube formation after co-culture. Further analysis of miR562 revealed that miR562-transfected cell conditioned media enhances endothelial cell tube formation, indicating that miR562 increased angiogenic secreted factors from MCF-7 breast tumor cells. TNF[alpha] was increased upon overexpression of miR562, which was reversed when ANXA1 was co-transfected In conclusion, this data suggests that ANXA1-regulated miR26b* and miR562 may play a role in wound healing and tumor-induced endothelial cell tube formation by targeting NF-[kappa]B expression and point towards a potential therapeutic target for breast cancer.
Publisher
Public Library of Science
Subject
